Market Cap 29.26M
Revenue (ttm) 0.00
Net Income (ttm) -39.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 878,800
Avg Vol 863,686
Day's Range N/A - N/A
Shares Out 17.01M
Stochastic %K 61%
Beta 1.41
Analysts Sell
Price Target $6.00

Company Profile

Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 967 6677
Address:
11 Commerce Drive, First Floor, Cranford, United States
SweStonk
SweStonk Oct. 24 at 1:36 PM
$CTXR gonna create even more bagholders! CTXR is worthless. He have been trying to sell Halo for years. They tried to sell ML to CRMD they said NO thank you. Only thing left is share distribution but the dilution have destroyed the value from it.
0 · Reply
Mapletreet
Mapletreet Oct. 24 at 1:28 PM
$CTXR Celebrating 🥳
0 · Reply
Jonesstock
Jonesstock Oct. 24 at 1:05 PM
$CTXR idk when but I will get my money back
1 · Reply
SweStonk
SweStonk Oct. 24 at 11:23 AM
$CTXR We will distribute the shares. We will distribute a portion of the shares. 2026 We wont distribute the shares. He will never leave the control of CTOR. It is his lifeboat and he will continue to dilute CTXR until it is completely drained.
0 · Reply
SweStonk
SweStonk Oct. 23 at 10:11 PM
$CTXR You will only get a portion of the shares 😂 He said he would distribute but not how much. He is bout to turn CTXR to a holding company.
1 · Reply
TwongStocks
TwongStocks Oct. 23 at 9:13 PM
$CTXR Updated investor slides https://s28.q4cdn.com/169506891/files/doc_presentations/2025/Oct/23/CTXR-Corporate-Overview-OCT-2025-FINAL.pdf
0 · Reply
TwongStocks
TwongStocks Oct. 23 at 3:48 PM
$CTOR $CTXR My favorite is when two people get in an an argument, but instead of keeping that argument in a single thread, they just continually quote each other.
2 · Reply
SweStonk
SweStonk Oct. 23 at 3:44 PM
$CTOR $CTXR Still 0 counter arguments to why anyone would be bullish. Atleast I give arguments to why Im bearish. You invest here for what? Third in line treatment that will bring 10m/y. They be lucky to get a couple patients on an already small patient population.
1 · Reply
BALUGA825
BALUGA825 Oct. 23 at 2:49 PM
$CTOR $CTXR So str8 up bashing this stock to get a discount. GOT IT!
1 · Reply
BALUGA825
BALUGA825 Oct. 22 at 9:47 PM
$CTOR $CTXR LoL Why would they beleive you held and sold ? Contradicting your post all the time. Your full of shit!
1 · Reply
Latest News on CTXR
Analysts Hunt for Undervalued Biotech Stocks

Jul 17, 2024, 8:00 AM EDT - 1 year ago

Analysts Hunt for Undervalued Biotech Stocks


Bloodstream Infections - From Threats to Solutions

Jul 11, 2024, 11:00 AM EDT - 1 year ago

Bloodstream Infections - From Threats to Solutions


SweStonk
SweStonk Oct. 24 at 1:36 PM
$CTXR gonna create even more bagholders! CTXR is worthless. He have been trying to sell Halo for years. They tried to sell ML to CRMD they said NO thank you. Only thing left is share distribution but the dilution have destroyed the value from it.
0 · Reply
Mapletreet
Mapletreet Oct. 24 at 1:28 PM
$CTXR Celebrating 🥳
0 · Reply
Jonesstock
Jonesstock Oct. 24 at 1:05 PM
$CTXR idk when but I will get my money back
1 · Reply
SweStonk
SweStonk Oct. 24 at 11:23 AM
$CTXR We will distribute the shares. We will distribute a portion of the shares. 2026 We wont distribute the shares. He will never leave the control of CTOR. It is his lifeboat and he will continue to dilute CTXR until it is completely drained.
0 · Reply
SweStonk
SweStonk Oct. 23 at 10:11 PM
$CTXR You will only get a portion of the shares 😂 He said he would distribute but not how much. He is bout to turn CTXR to a holding company.
1 · Reply
TwongStocks
TwongStocks Oct. 23 at 9:13 PM
$CTXR Updated investor slides https://s28.q4cdn.com/169506891/files/doc_presentations/2025/Oct/23/CTXR-Corporate-Overview-OCT-2025-FINAL.pdf
0 · Reply
TwongStocks
TwongStocks Oct. 23 at 3:48 PM
$CTOR $CTXR My favorite is when two people get in an an argument, but instead of keeping that argument in a single thread, they just continually quote each other.
2 · Reply
SweStonk
SweStonk Oct. 23 at 3:44 PM
$CTOR $CTXR Still 0 counter arguments to why anyone would be bullish. Atleast I give arguments to why Im bearish. You invest here for what? Third in line treatment that will bring 10m/y. They be lucky to get a couple patients on an already small patient population.
1 · Reply
BALUGA825
BALUGA825 Oct. 23 at 2:49 PM
$CTOR $CTXR So str8 up bashing this stock to get a discount. GOT IT!
1 · Reply
BALUGA825
BALUGA825 Oct. 22 at 9:47 PM
$CTOR $CTXR LoL Why would they beleive you held and sold ? Contradicting your post all the time. Your full of shit!
1 · Reply
SweStonk
SweStonk Oct. 22 at 8:03 PM
$CTOR $CTXR You should read before comment. You should re read before sharing. I have no position here. Sold @ ~$2.1 on CTXR and ~$2.66 on CTOR. Mazur will never give up CTOR. If he distribute he wont have full control. When he choose to sell ML and not the company it is clear as day. Why do you think the SP have dropped this much after the conference? Why Mazur didnt hold the conference? Some people really want nothing more than to blow their portfolio..... SAVA all over this.
0 · Reply
NYC100
NYC100 Oct. 22 at 6:56 PM
$CTOR $CTXR I think you should sell it if you’re so afraid
1 · Reply
SweStonk
SweStonk Oct. 22 at 5:54 PM
$CTOR $CTXR He about to fuck every investor in CTXR. Selling the main asset and not the company(CTXR) and already spun off the other asset(lymphir) is very bad news. CTXR will be worthless and only a holding company while management benefit from getting free shares in CTOR. There are only a handful of companies that have done this before and they all went bankrupt. This is very bad news. When trust is gone so is the company. What makes you think it will be different in CTOR? After investors know what he have done why would anyone trust him with their own money? I have waited for an opportunity to enter cheaper because of ML but this is very very slimy of him. Their estimates are completely off for Lymphir and it seems they are trying to blow up the value. Competition with more patients and better efficiancy dont have revenue anywhere near their estimates. Never thought in my life that applebot was about to be correct about all of this.
0 · Reply
SweStonk
SweStonk Oct. 22 at 5:38 PM
$CTXR No wonder for the first time in 5 years that Mazur dont hold the conference. They never said that they will sell CTXR but only the assets(ML and Halo). They will turn CTXR into a holding company and will distribute the shares when they are done with CTOR which is years away(or never) if we gonna follow the recent shares award for Mazur and his buddies. By doing this CTXR will be worthless. Only a few companies have ever done this before and they all went bankrupt. When trust is gone from the investors so is the company. Selling your only asset instead of the company(CTXR) is relly really bad news for every investor here. This is not like any regular BO.
0 · Reply
st0ckt1cker
st0ckt1cker Oct. 22 at 2:06 PM
$CTXR so finally a release of the drug and the stock is dropping, I just don’t get it
1 · Reply
st0ckt1cker
st0ckt1cker Oct. 22 at 1:51 PM
$CTXR I honestly don’t know if I should hold or sell…damn, especially if news finally a release is upcoming
1 · Reply
Noname2022
Noname2022 Oct. 22 at 10:01 AM
$CRMD $CTXR Mino Lok is for sale https://www.reddit.com/r/CTXR/comments/1oclm08/recap_ld_micro_main_event_oct_21/
6 · Reply
BALUGA825
BALUGA825 Oct. 21 at 11:22 PM
$CTOR $CTXR Let me get this str8: FDA approved drug will be launch this month and the other d4ug on phase 3 trial will get a green light this year. Did i read that right ?
0 · Reply
SweStonk
SweStonk Oct. 21 at 8:51 PM
$CTXR We are supposed to trust Mazur will distribute after he sells ML? Will he give up his power in CTOR? He is banking on CTOR and have planned 5 years ahead of printing free sharea to himself. Seems like Applebot was correct about Mazurs lifeboat and CTXR will turn to a holding company. He wont distribute anything until he is able to sell CTOR which is years away.
0 · Reply
TwongStocks
TwongStocks Oct. 21 at 8:51 PM
$CTXR SEC filing confirms a 90 day lockup. One exception is that they can use the ATM after 30 days, but only above $2.15 https://www.sec.gov/ix?doc=/Archives/edgar/data/1506251/000121390025100847/ea0261909-8k_citius.htm "Pursuant to the Purchase Agreement, the Company agreed for a period of 90 days following the closing of the Offering not to issue, enter into an agreement to issue or announce the issuance or proposed issuance of the shares or any other securities convertible into, or exercisable or exchangeable for, shares of common stock, subject to certain exceptions; provided that after 30 days after closing, the Company may issue shares of common stock in an “at the market” offering with the placement agent as sales agent at an offering price equal to or greater than $2.15 per share." Earliest $CTOR can raise again is Nov 14, when the lockup from their Sept offering expires. Earliest CTXR can raise again is Jan 19, 2026, ninety days from today.
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Oct. 21 at 7:39 PM
$CTXR I'll keep watch of this to see where Halo-Lido ends up, after it gets sold off. I'm done trying to follow the shill.
0 · Reply
TwongStocks
TwongStocks Oct. 21 at 7:00 PM
$CTXR $CTOR Recap of today's presentation. Interestingly, Leonard did not give the presentation. This was Paul Sowyrda, VP of Business Development & Market Intelligence. LYMPHIR • During the Q&A, he stated that they were planning to launch LYMPHIR by the end of the month • In process of signing additional international agreements for LYMPHIR, plan to cover 38 countries by EoY. Price of drug in US is expected to be $326,000 per patient per year • Expect year initial sales to be under $100M in first 12 months, profitable within first 9 months. Year 4 sales expected to be $400M • Trial combining LYMPHIR with KEYTRUDA: seeing 40% ORR in in-stage GYN cancers & they are in mature discusssions with Merck • Trial combining LYMPHIR with CAR-T: seeing 91% resposne rates in refractory B-cell lymphomas • CTOR has 18 months of LYMPHIR in inventory. CTOR raised $9M last month, will be doing another raise in the next few weeks to support the commercial launch More in comments
4 · Reply